ISRG Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.9B
+4.4%
2.8B
-3.3%
2.9B
+14.4%
2.5B
+2.7%
2.4B
Cost of Revenue
931.9M
-0.9%
940.3M
-2.2%
961.9M
+14.1%
842.7M
+2.5%
822.1M
Gross Profit
2.0B
+7.1%
1.8B
-3.9%
1.9B
+14.6%
1.7B
+2.8%
1.6B
Operating Expenses
988.5M
+1.4%
975.2M
-6.2%
1.0B
+15.2%
902.7M
+3.2%
874.5M
R&D
370.6M
+2.4%
361.9M
+2.6%
352.9M
+7.1%
329.4M
+5.1%
313.3M
SG&A
617.9M
+0.8%
613.3M
-10.7%
687.1M
+19.8%
573.3M
+2.2%
561.2M
Operating Income
971.9M
+13.6%
855.3M
-1.0%
864.3M
+13.8%
759.7M
+2.2%
743.4M
EBITDA
1.0B
+15.3%
876.4M
-41.7%
1.5B
+94.7%
772.6M
+2.2%
755.7M
Net Income
823.2M
-0.3%
826.0M
+3.3%
799.5M
+12.7%
709.2M
+6.8%
664.2M
EPS (Basic)
$2.31
+0.0%
$2.31
+3.1%
$2.24
+13.1%
$1.98
+7.6%
$1.84
EPS (Diluted)
$2.29
+0.4%
$2.28
+3.2%
$2.21
+13.3%
$1.95
+7.7%
$1.81
Shares (Diluted)
357.3M
-0.7%
359.8M
-0.1%
360.3M
-0.4%
361.8M
-0.6%
364.1M
Intuitive Surgical (ISRG) โ€” Financials